Author:
Menassa Jeanine,Bou Nassar Dima,El Naboulsi Farah,El Naggar Essam,Sunna Nancy,Ghoubar Marcelle
Abstract
Background:
Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with substantial disease burdens, including impaired quality of life, functional disability, and lost productivity. Early diagnosis and effective treatment are essential to reducing disease burden and improving long-term outcomes but remain difficult to achieve.
Methods:
To better understand the deficiencies contributing to diagnostic and therapeutic delays in RA and AS in Lebanon, a computer-assisted survey of 1,200 Lebanese citizens was conducted about their awareness and knowledge of these diseases, including characteristics and management.
Results:
Approximately two-thirds and one-third of the survey participants had heard of RA and AS, respectively; two-thirds admitted they knew little about either disease after interviewers provided detailed descriptions. Most participants were aware of the major signs and symptoms of the disease, but most were unaware of serious related comorbidities and complications. While 63% identified rheumatologists as healthcare providers specializing in RA treatment, 89% indicated orthopedists were treating physicians for AS. More than three-quarters of participants understood that early treatment can be effective in RA and AS in preventing disease progression and joint damage, but two-thirds mistakenly considered treatment to be a cure. Among participants who had RA vs AS (57 [4.8%] vs 28 [2.3%]), 21.1% vs 7.1% visited a rheumatologist when initially experiencing symptoms; 64.9% vs 35.7% visited a rheumatologist for follow-up care after diagnosis.
Conclusion:
To close gaps in knowledge and management of RA and AS, initiatives are needed to raise public awareness and educate patients and healthcare providers about the importance of early diagnosis and effective treatment.
Publisher
Bentham Science Publishers Ltd.
Reference34 articles.
1. Gabriel SE, Michaud K.
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
Arthritis Res Ther
2009;
11
(3)
: 229.
2. Rafia R, Ara R, Packham J, Haywood KL, Healey E.
Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.
Clin Exp Rheumatol
2012;
30
(2)
: 246.
3. Boonen A, Mau W.
The economic burden of disease: Comparison between rheumatoid arthritis and ankylosing spondylitis.
Clin Exp Rheumatol
2009;
27
(4)
: S112-7.
4. Jacobs P, Bissonnette R, Guenther LC.
Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability.
J Rheumatol Suppl
2011;
88
(0)
: 55-61.
5. Kiltz U, van der Heijde D.
Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis.
Clin Exp Rheumatol
2009;
27
(4)
: S108-11.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献